Chlorhexidine gluconate-impregnated central access catheter dressings as a cause of erosive contact dermatitis: A report of 7 cases

JAMA Dermatology

Volumn 149, Issue 2, 2013, Pages 195-199

  Weitz, Nicole A ^a   Lauren, Christine T ^a   Weiser, Jessica A ^a   LeBoeuf, Nicole R ^a   Grossman, Marc E ^a   Biagas, Katherine ^a   Garzon, Maria C ^a   Morel, Kimberly D ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CHLORHEXIDINE GLUCONATE;

ADULT; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; CONTACT DERMATITIS; DEATH; DEVICE REMOVAL; EROSIVE CONTACT DERMATITIS; ERYTHEMA; HUMAN; IIMPREGNATED GEL PAD DRESSING; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INGUINAL REGION; INTENSIVE CARE UNIT; MALE; MICROBIOLOGICAL EXAMINATION; OCCLUSIVE DRESSING; ORGAN TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; THIGH; WOUND CARE;

ANTI-INFECTIVE AGENTS, LOCAL; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHILD, PRESCHOOL; CHLORHEXIDINE; CRITICAL ILLNESS; DERMATITIS, IRRITANT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MIDDLE AGED; OCCLUSIVE DRESSINGS; ORGAN TRANSPLANTATION; SEPSIS;

EID: 84874286122     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.903     Document Type: Article

References (20)

1. Hodge D, Puntis JWL. Diagnosis, prevention, and management of catheter related bloodstream infection during long term parenteral nutrition. Arch Dis Child Fetal Neonatal Ed. 2002;87(1):F21-F24.
2. Timsit JF, Schwebel C, Bouadma L, et al Dressing Study Group. Chlorhexidineimpregnated sponges and less frequent dressing changes for prevention of catheter- related infections in critically ill adults: a randomized controlled trial. JAMA. 2009;301(12):1231-1241.
3. Levy I, Katz J, Solter E, et al. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study. Pediatr Infect Dis J. 2005;24(8):676-679.
4. Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidoneiodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics. 2001;107(6):1431-1436.
5. Roberts BL, Cheung D. Biopatch: a new concept in antimicrobial dressings for invasive devices. Aust Crit Care. 1998;11(1):16-19.
6. Gimenez-Arnau AM. Occupational contact dermatitis. In: Johanson JD, Frosch PJ, Lepoittevin JP, eds. Contact Dermatitis. Heidelberg, Germany: Springer; 2011: 841-851.
7. Lauerma AI. Simultaneous immediate and delayed hypersensitivity to chlorhexidine digluconate. Contact Dermatitis. 2001;44(1):59. doi:10.1034/j.1600-0536 .2001.440107-8.x.
8. Ebo DG, Stevens WJ, Bridts CH, Matthieu L. Contact allergic dermatitis and lifethreatening anaphylaxis to chlorhexidine. J Allergy Clin Immunol. 1998;101 (1, pt 1):128-129.
9. Torricelli R, Wüthrich B. Life-threatening anaphylactic shock due to skin application of chlorhexidine [correspondence]. Clin Exp Allergy. 1996;26(1):112.
10. Goon AT, White IR, Rycroft RJ, McFadden JP. Allergic contact dermatitis from chlorhexidine. Dermatitis. 2004;15(1):45-47.
11. Le Corre Y, Barbarot S, Frot AS, Milpied B. Allergic contact dermatitis to chlorhexidine in a very young child. Pediatr Dermatol. 2010;27(5):485-487.
12. Mailhol C, Lauwers-Cances V, Rancé F, Paul C, Giordano-Labadie F. Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children. Allergy. 2009;64(5):801-806.
13. Liippo J, Kousa P, Lammintausta K. The relevance of chlorhexidine contact allergy. Contact Dermat. 2011;64(4):229-234.
14. Rustemeyer T, van Hoogstraten IMW, von Bomberg BME, et al. Mechanisms of irritant and allergic contact dermatitis. In: Johanson JD, Frosch PJ, Lepoittevin JP, eds. Contact Dermatitis. Heidelberg, Germany: Springer; 2011:43-75.
15. Nikolovski J, Stamatas GN, Kollias N, Wiegand BC. Barrier function and waterholding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life. J Invest Dermatol. 2008;128(7):1728-1736.
16. Zhai H, Meier-Davis SR, Cayme R, Shudo J, Maibach H. Irritant contact dermatitis: effect of age. Cutan Ocul Toxicol. 2012;31(2):138-143.
17. Frosch PJ, John SM. Clinical aspects of irritant contact dermatitis. In: Johanson JD, Frosch PJ, Lepoittevin JP, eds. Contact Dermatitis. Heidelberg, Germany: Springer; 2011:305-327.
18. Chapman AK, Aucott SW, Milstone AM. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant. J Perinatol. 2012;32(1):4-9.
19. Material Safety Data Sheet 3MTM TegadermTM w/CHG (1657, 1658, 1659, 1660). February 8, 2011. http://multimedia.3m.com/mws/mediawebserver?mwsId =SSSSSuUn-zu8l00x4xt958tBlv70k17zHvu9lxtD7SSSSSS-. Accessed May 25, 2012.
20. McCleskey PE. Dermatitis to FD&C yellow No. 6 dye in orange antiseptic solution. Arch Dermatol. 2011;147(9):1124-1125.